82 related articles for article (PubMed ID: 10374318)
1. [Study on p53, mdm-2 and p21WAF1 protein expression in ER-positive and ER-negative human breast cancer cell lines and its relation to biological features].
Jiang M; Shao Z; Zhang Y
Zhonghua Bing Li Xue Za Zhi; 1997 Dec; 26(6):327-30. PubMed ID: 10374318
[TBL] [Abstract][Full Text] [Related]
2. [WAF1/CIP1/p21 gene in wild type p53 and mutant p53 human breast cancer cell lines in relation to its cytobiological features].
Jiang M; Shao Z; Wu J
Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):181-4. PubMed ID: 10921001
[TBL] [Abstract][Full Text] [Related]
3. p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis.
Jiang M; Shao ZM; Wu J; Lu JS; Yu LM; Yuan JD; Han QX; Shen ZZ; Fontana JA
Int J Cancer; 1997 Oct; 74(5):529-34. PubMed ID: 9355976
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
Sjöström J; Blomqvist C; Heikkilä P; Boguslawski KV; Räisänen-Sokolowski A; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Bergh J; Wist E; Valvere V; Saksela E
Clin Cancer Res; 2000 Aug; 6(8):3103-10. PubMed ID: 10955790
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.
Liu W; Zhang R
Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438
[TBL] [Abstract][Full Text] [Related]
6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
7. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells.
Majumder B; Wahle KW; Moir S; Schofield A; Choe SN; Farquharson A; Grant I; Heys SD
FASEB J; 2002 Sep; 16(11):1447-9. PubMed ID: 12205043
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous conversion to estrogen receptor expression by the human breast epithelial cell line, MCF-10A.
Lane MA; Romagnoli L; Cruise B; Cohn GM
Oncol Rep; 1999; 6(3):507-11. PubMed ID: 10203582
[TBL] [Abstract][Full Text] [Related]
9. Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53.
Wang JA; Fan S; Yuan RQ; Ma YX; Meng Q; Goldberg ID; Rosen EM
Int J Radiat Biol; 1999 Mar; 75(3):301-16. PubMed ID: 10203181
[TBL] [Abstract][Full Text] [Related]
10. The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma.
Sheikh MS; Shao ZM; Hussain A; Fontana JA
Cancer Res; 1993 Jul; 53(14):3226-8. PubMed ID: 8324731
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma.
Bánkfalvi A; Tory K; Kemper M; Breukelmann D; Cubick C; Poremba C; Füzesi L; Lellè RJ; Böcker W
Pathol Res Pract; 2000; 196(7):489-501. PubMed ID: 10926327
[TBL] [Abstract][Full Text] [Related]
12. p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.
Giannikaki E; Kouvidou C; Tzardi M; Stefanaki K; Koutsoubi K; Gregoriou M; Zois E; Kakolyris S; Mavroudi C; Delides G; Georgoulias V; Kanavaros P
Anticancer Res; 1997; 17(3C):2123-7. PubMed ID: 9216675
[TBL] [Abstract][Full Text] [Related]
13. Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors.
Sourvinos G; Spandidos DA
Biochem Biophys Res Commun; 1998 Apr; 245(1):75-80. PubMed ID: 9535786
[TBL] [Abstract][Full Text] [Related]
14. [Gastric cancer and tumor growth regulation. Study of cell proliferation markers and protein complex p53/p21WAF1/CIP1/mdm-2].
Villaseca M; Araya JC; Roa I; Roa JC
Rev Med Chil; 2000 Feb; 128(2):127-36. PubMed ID: 10962880
[TBL] [Abstract][Full Text] [Related]
15. Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma.
Suzuki A; Toi M; Yamamoto Y; Saji S; Muta M; Tominaga T
Jpn J Cancer Res; 1998 Feb; 89(2):221-7. PubMed ID: 9548451
[TBL] [Abstract][Full Text] [Related]
16. Changes in p21WAF1, pRb, Mdm-2, Bax and Bcl-2 expression in cervical cancer cell lines transfected with a p53 expressing adenovirus.
Huang TG; Ip SM; Yeung WS; Ngan HY
Eur J Cancer; 2000 Jan; 36(2):249-56. PubMed ID: 10741285
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
18. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
19. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression.
Grand RJ; Lecane PS; Owen D; Grant ML; Roberts S; Levine AJ; Gallimore PH
Virology; 1995 Jul; 210(2):323-34. PubMed ID: 7618270
[TBL] [Abstract][Full Text] [Related]
20. Expression of p21waf1/Cip1, MDM2 and p53 in vivo: analysis of cytological preparations.
Dowell SP; McGoogan E; Picksley SM; el-Deiry WS; Vogelstein B; Hall PA
Cytopathology; 1996 Oct; 7(5):340-51. PubMed ID: 8911758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
